Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ · Healthcare
Vertex Pharmaceuticals Incorporated Price to FCF Ratio 2006–2026
Price to free cash flow (P/FCF) ratio for Vertex Pharmaceuticals Incorporated (VRTX): market cap divided by trailing twelve-month free cash flow. As of March 31, 2026 it is 35.83.
From: 03/31/2010To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Vertex Pharmaceuticals Inc. Price to FCF Ratio — FAQ
Vertex Pharmaceuticals Inc. (VRTX) price to fcf ratio over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRTX's price to fcf ratio history?
The chart and table above show Vertex Pharmaceuticals Inc.'s price to fcf ratio by year and by quarter, including the growth rate.